Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29220608 | 1.00 | TP53 (0.31) | TP53SLC22A6TSHR | |
| SCHEMBL29170947 | 1.00 | TP53 (0.31) | TP53SLC22A6TSHR | |
| SCHEMBL143527 | 0.97 | TP53 (0.32) | TP53SLC22A6TSHR | |
| SCHEMBL27955381 | 0.94 | TP53 (0.31) | TP53SLC22A6TSHR | |
| SCHEMBL29170913 | 0.94 | TP53 (0.31) | TP53SLC22A6TSHR | |
| Ammonia Solution, Strong SCHEMBL23795559 | 0.94 | TP53 (0.31) | TP53SLC22A6TSHR | |
| SCHEMBL16756646 | 0.94 | TP53 (0.31) | TP53SLC22A6TSHR | |
| Ammonia Solution, Strong SCHEMBL23795565 | 0.94 | TP53 (0.31) | TP53SLC22A6TSHR | |
| Ethylene SCHEMBL29170908 | 0.91 | LAP3 (0.31) | TP53 | |
| Propene SCHEMBL23700077 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240402196-A1 | Method for Stabilizing Hemoglobin and Reagents for Performing the Same | EXACT SCIENCES CORPORATION | 2024-12-05 | — | — | US | disclosed |
| EP-3773236-B1 | METHOD FOR STABILIZING HEMOGLOBIN AND REAGENTS FOR PERFORMING THE SAME | EXACT SCIENCES CORP (US) | 2024-07-17 | — | — | EP | disclosed |
| US-11994524-B2 | Method for stabilizing hemoglobin and reagents for performing the same | EXACT SCIENCES CORPORATION (US) | 2024-05-28 | — | — | US | disclosed |
| US-11703512-B2 | Method for stabilizing hemoglobin and reagents for performing the same | EXACT SCIENCES CORPORATION (US) | 2023-07-18 | — | — | US | disclosed |
| US-20230221340-A1 | METHOD FOR STABILIZING HEMOGLOBIN AND REAGENTS FOR PERFORMING THE SAME | JPMORGAN CHASE BANK, N.A. | 2023-07-13 | — | — | US | disclosed |
| US-11385243-B2 | Method for stabilizing hemoglobin and reagents for performing the same | EXACT SCIENCES CORPORATION (US) | 2022-07-12 | — | — | US | disclosed |
| US-20190302129-A1 | METHOD FOR STABILIZING HEMOGLOBIN AND REAGENTS FOR PERFORMING THE SAME | JPMORGAN CHASE BANK, N.A. | 2019-10-03 | — | — | US | disclosed |
| EP-2944308-A1 | Formulations and methods for treating chronic infection | Kiacta Sàrl (CH) | 2015-11-18 | — | — | EP | disclosed |
| EP-1885350-B9 | FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS | KIACTA S RL (CH) | 2015-06-17 | — | — | EP | disclosed |
| EP-1885350-B1 | FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS | KIACTA S RL (CH) | 2015-03-04 | — | — | EP | disclosed |
| EP-1968561-B1 | TREATMENT OF DIABETIC NEPHROPATHY | BELLUS HEALTH INT LTD (CH) | 2010-09-15 | — | — | EP | disclosed |
| EP-2120905-A1 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES | BELLUS Health (International) Limited (CH) | 2009-11-25 | — | — | EP | disclosed |
| US-20080262088-A1 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES | KIACTA SARL (CH) | 2008-10-23 | — | — | US | disclosed |
| EP-1968561-A2 | TREATMENT OF RENAL DISORDERS, DIABETIC NEPHROPATHY AND DYSLIPIDEMIAS | Neurochem (International) Limited (CH) | 2008-09-17 | — | — | EP | disclosed |
| WO-2008078176-A1 | METHODS, COMPOUNDS, AND COMPOSITIONS FOR TREATING METABOLIC DISORDERS AND DIABETES | BELLUS HEALTH (INTERNATIONAL) LIMITED (US) | 2008-07-03 | — | — | WO | disclosed |
| EP-1885350-A2 | FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS | Neurochem (International) Limited (CH) | 2008-02-13 | — | — | EP | disclosed |
| WO-2007125385-A2 | TREATMENT OF RENAL DISORDERS, DIABETIC NEPHOPATHY AND DYSLIPIDEMIAS | NEUROCHEM (INTERNATIONAL) LIMITED (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070238788-A1 | Treatment of renal disorders, diabetic nephropathy and dyslipidemias | KIACTA SARL (CH) | 2007-10-11 | — | — | US | disclosed |
| WO-2007004072-A2 | FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-01-11 | — | — | WO | disclosed |
| US-20060252829-A1 | Formulations and methods for treating amyloidosis | KIACTA SARL (CH) | 2006-11-09 | — | — | US | disclosed |